Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/ALNYLAM-PHARMACEUTICALS-I-8322/nieuws/Alnylam-presenteert-positieve-18-maanden-resultaten-van-HELIOS-A-Fase-3-studie-van-het-onderzoek-Vut-37613988/?utm_source=whatsapp&utm_medium=social&utm_campaign=share